These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28090226)

  • 1. More Use of Peritoneal Dialysis Gives Significant Savings: A Systematic Review and Health Economic Decision Model.
    Pike E; Hamidi V; Ringerike T; Wisloff T; Klemp M
    J Clin Med Res; 2017 Feb; 9(2):104-116. PubMed ID: 28090226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
    Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal dialysis vs. hemodialysis among patients with end-stage renal disease in Iran: which is more cost-effective?
    Yousefi M; Rezaei S; Hajebrahimi S; Falsafi N; Keshvari-Shad F
    BMC Nephrol; 2024 Mar; 25(1):85. PubMed ID: 38448887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
    Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial implications of dialysis modalities in the developing world: A Chinese perspective.
    Liu J; Hutton DW; Gu Y; Hu Y; Li Y; Ma L; Zeng X; Fu P
    Perit Dial Int; 2020 Mar; 40(2):193-201. PubMed ID: 32063196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-Hospital Mortality in Cirrhotic Patients with End-Stage Renal Disease Treated with Hemodialysis Versus Peritoneal Dialysis: A Nationwide Study.
    Nader MA; Aguilar R; Sharma P; Krishnamoorthy P; Serban D; Gordon-Cappitelli J; Shen W; Nilubol C; Li P; Lipkowitz M
    Perit Dial Int; 2017; 37(4):464-471. PubMed ID: 28348101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis.
    Liu FX; Treharne C; Culleton B; Crowe L; Arici M
    BMC Nephrol; 2014 Oct; 15():161. PubMed ID: 25278356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost Controversies of a "Home Dialysis First" Policy.
    Hager D; Ferguson TW; Komenda P
    Can J Kidney Health Dis; 2019; 6():2054358119871541. PubMed ID: 31516718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
    Teerawattananon Y; Mugford M; Tangcharoensathien V
    Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal Dialysis in Asia.
    Kwong VW; Li PK
    Kidney Dis (Basel); 2015 Dec; 1(3):147-56. PubMed ID: 27536675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China.
    Yang F; Liao M; Wang P; Liu Y
    BMJ Open; 2021 Feb; 11(2):e039653. PubMed ID: 33550227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.
    Vidal E; van Stralen KJ; Chesnaye NC; Bonthuis M; Holmberg C; Zurowska A; Trivelli A; Da Silva JEE; Herthelius M; Adams B; Bjerre A; Jankauskiene A; Miteva P; Emirova K; Bayazit AK; Mache CJ; Sánchez-Moreno A; Harambat J; Groothoff JW; Jager KJ; Schaefer F; Verrina E;
    Am J Kidney Dis; 2017 May; 69(5):617-625. PubMed ID: 27955924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands.
    Beby AT; Cornelis T; Zinck R; Liu FX
    Adv Ther; 2016 Nov; 33(11):2032-2048. PubMed ID: 27664108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of contemporary home haemodialysis modalities compared with facility haemodialysis: a systematic review of full economic evaluations.
    Walker R; Marshall MR; Morton RL; McFarlane P; Howard K
    Nephrology (Carlton); 2014 Aug; 19(8):459-70. PubMed ID: 24750559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.
    Wong B; Ravani P; Oliver MJ; Holroyd-Leduc J; Venturato L; Garg AX; Quinn RR
    Am J Kidney Dis; 2018 Mar; 71(3):344-351. PubMed ID: 29174322
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.